AMLXAmylyx Pharmaceuticals, Inc.

AMLX Stock Price, Valuation & Chart | Amylyx Pharmaceuticals, Inc.

Compare

$34.490+0.68 (+2.01%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology AMLX intrinsic value AMLX calculated fair value vs price

Overview Financials Dividends Ratios

AMLX Historical price chart

AMLX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.83B

PE Ratio-22.99

EPS-1.5

Trading Volume1.83M

Today's High/Low35.48/34.0

Dividend Yield0.00

52 Week High/Low41.14/9.61

Shares Outstanding111.19M

AMLX Financial Statement

AMLX Analyst ratings

AMLX Analysis & performance metrics

AMLX Company profile

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other…

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is…

AMLX Management team

Name

Position

Jamie Timmons

Head of Global Medical Strategy & Communications

Linda A. Arsenault

Chief Human Resources Officer

Lindsey Allen

Head of Investor Relations & Communications

Joshua B. CohenCEO

Co-Founder, Co-Chief Executive Officer & Director

James M. Frates M.B.A.CFO

Chief Financial Officer

Tom Holmes

Chief Technical Operations Officer

Tammy Sarnelli

Global Head of Regulatory Affairs

Machelle Manuel Ph.D.

Vice President & Head of Global Medical Affairs

Name

Position

Jamie Timmons

Head of Global Medical Strategy & Communications

Linda A. Arsenault

Chief Human Resources Officer

Lindsey Allen

Head of Investor Relations & Communications

Joshua B. CohenCEO

Co-Founder, Co-Chief Executive Officer & Director

James M. Frates M.B.A.CFO

Chief Financial Officer

Tom Holmes

Chief Technical Operations Officer

Tammy Sarnelli

Global Head of Regulatory Affairs

Machelle Manuel Ph.D.

Vice President & Head of Global Medical Affairs

Management Team

Jamie Timmons

Head of Global Medical Strategy & Communications

Linda A. Arsenault

Chief Human Resources Officer

Lindsey Allen

Head of Investor Relations & Communications

Joshua B. CohenCEO

Co-Founder, Co-Chief Executive Officer & Director

James M. Frates M.B.A.CFO

Chief Financial Officer

Tom Holmes

Chief Technical Operations Officer

Tammy Sarnelli

Global Head of Regulatory Affairs

Machelle Manuel Ph.D.

Vice President & Head of Global Medical Affairs

Management

Jamie Timmons

Head of Global Medical Strategy & Communications

Linda A. Arsenault

Chief Human Resources Officer

Lindsey Allen

Head of Investor Relations & Communications

Joshua B. CohenCEO

Co-Founder, Co-Chief Executive Officer & Director

James M. Frates M.B.A.CFO

Chief Financial Officer

Tom Holmes

Chief Technical Operations Officer

Tammy Sarnelli

Global Head of Regulatory Affairs

Machelle Manuel Ph.D.

Vice President & Head of Global Medical Affairs

Total 8 executives

AMLX Frequently asked questions

What is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price?

Current stock price of Amylyx Pharmaceuticals, Inc. (AMLX) stock is $34.490. The stock price is +2.01% higher in the session. The intraday range can be seen from this page. Volume of Amylyx Pharmaceuticals, Inc. (AMLX) stock is 1.83M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Amylyx Pharmaceuticals, Inc. (AMLX) stock price going up or down today?

The stock price of Amylyx Pharmaceuticals, Inc. (AMLX) can change with earnings, company news, and overall market sentiment. Amylyx Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Amylyx Pharmaceuticals, Inc. stock expensive at its current price?

Whether Amylyx Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AMLX on this page is -22.99. EPS on this page is -1.50. Compare those figures with peers and growth expectations before deciding if the current Amylyx Pharmaceuticals, Inc. price is justified.

How has the stock price of Amylyx Pharmaceuticals, Inc. (AMLX) performed historically?

Historical performance for Amylyx Pharmaceuticals, Inc. (AMLX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AMLX reacted to past earnings and market events.

Should I buy Amylyx Pharmaceuticals, Inc. (AMLX) stock, at this price?

Buying Amylyx Pharmaceuticals, Inc. (AMLX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.